392 related articles for article (PubMed ID: 28438935)
1. Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.
Marcos-Zambrano LJ; Puig-Asensio M; Pérez-García F; Escribano P; Sánchez-Carrillo C; Zaragoza O; Padilla B; Cuenca-Estrella M; Almirante B; Martín-Gómez MT; Muñoz P; Bouza E; Guinea J
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438935
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Clinical features, antifungal susceptibility, and outcome of Candida guilliermondii fungemia: An experience in a tertiary hospital in mid-Taiwan.
Tseng TY; Chen TC; Ho CM; Lin PC; Chou CH; Tsai CT; Wang JH; Chi CY; Ho MW
J Microbiol Immunol Infect; 2018 Aug; 51(4):552-558. PubMed ID: 28625801
[TBL] [Abstract][Full Text] [Related]
4. Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality.
Soldini S; Posteraro B; Vella A; De Carolis E; Borghi E; Falleni M; Losito AR; Maiuro G; Trecarichi EM; Sanguinetti M; Tumbarello M
Clin Microbiol Infect; 2018 Jul; 24(7):771-777. PubMed ID: 29133157
[TBL] [Abstract][Full Text] [Related]
5. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
7. Association of different Candida species with catheter-related candidemia, and the potential antifungal treatments against their adhesion properties and biofilm-forming capabilities.
Zuo XS; Liu Y; Cai X; Zhan L; Hu K
J Clin Lab Anal; 2021 Apr; 35(4):e23738. PubMed ID: 33608902
[TBL] [Abstract][Full Text] [Related]
8. Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.
Simitsopoulou M; Peshkova P; Tasina E; Katragkou A; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2013 Jun; 57(6):2562-70. PubMed ID: 23529739
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10.
Chen CY; Huang SY; Tang JL; Tsay W; Yao M; Ko BS; Chou WC; Tien HF; Hsueh PR
J Antimicrob Chemother; 2013 Nov; 68(11):2632-5. PubMed ID: 23766486
[TBL] [Abstract][Full Text] [Related]
10. Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures.
Sriphannam C; Nuanmuang N; Saengsawang K; Amornthipayawong D; Kummasook A
J Mycol Med; 2019 Dec; 29(4):325-330. PubMed ID: 31447236
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
Med Mycol; 2016 Feb; 54(2):155-61. PubMed ID: 26543157
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
[TBL] [Abstract][Full Text] [Related]
13. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
[TBL] [Abstract][Full Text] [Related]
14. Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan.
Chang TP; Ho MW; Yang YL; Lo PC; Lin PS; Wang AH; Lo HJ
J Infect Chemother; 2013 Dec; 19(6):1065-71. PubMed ID: 23732308
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study.
Breda GL; Tuon FF; Meis JF; Herkert PF; Hagen F; de Oliveira LZ; Dias VC; da Cunha CA; Queiroz-Telles F
Med Mycol; 2018 Jun; 56(4):406-415. PubMed ID: 29420820
[TBL] [Abstract][Full Text] [Related]
16. Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia.
Kraft L; Ribeiro VST; Gonçalves GA; Suss PH; Tuon FF
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Dec; 41(10):596-603. PubMed ID: 36707288
[TBL] [Abstract][Full Text] [Related]
17. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
[TBL] [Abstract][Full Text] [Related]
18. Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study.
Jensen RH; Johansen HK; Søes LM; Lemming LE; Rosenvinge FS; Nielsen L; Olesen B; Kristensen L; Dzajic E; Astvad KM; Arendrup MC
Antimicrob Agents Chemother; 2015 Dec; 60(3):1500-8. PubMed ID: 26711776
[TBL] [Abstract][Full Text] [Related]
19. Changing epidemiology of candidemia in a medical center in middle Taiwan.
Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
[TBL] [Abstract][Full Text] [Related]
20. Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina.
Vigezzi C; Icely PA; Dudiuk C; Rodríguez E; Miró MS; Castillo GDV; Azcurra AI; Abiega C; Caeiro JP; Riera FO; García-Effrón G; Sotomayor CE
J Mycol Med; 2019 Dec; 29(4):285-291. PubMed ID: 31668524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
